Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

PHILADELPHIA — An oral investigational aldosterone synthase inhibitor (ASI) cut albuminuria by nearly 40% in people in chronic kidney disease (CKD) in a phase II

Anima’s Lighting platform uses machine learning to identify therapeutically relevant mRNAs. Credit: Chaosamran_Studio/ Shutterstock Anima Biotech is utilising machine learning (ML) to investigate the role